Texas Retina Associates
5 clinical trials · Sponsor
◉ Watch Texas Retina Associates
| Record | Firm | Date |
|---|---|---|
| The Use of Two YUTIQ Versus Sham for Treatment of Chronic Non Infectious Intraocular Inflammation Affecting the Posterior Segment (NCT05486468) | Texas Retina Associates | 2022-10-05 |
| One Year Trial Evaluating Safety of Ozurdex With Eylea (NCT03984110) | Texas Retina Associates | 2019-06-11 |
Track Texas Retina Associates automatically
Every clearance here is in the API, with alerts when new ones post.